Search
01/02/2022
Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry
El-Chami, MF, Garweg, C, Iacopino, S, Al-Samadi, F, Martinez-Sande, JL, Tondo, C, Johansen, JB, Prat, XV, Piccini, JP, Cha, YM, Grubman, E, Bordachar, P, Roberts, PR, Soejima, K, Stromberg, K, Fagan, DH, Clementy, N. Leadless pacemaker implant, anticoagulation status, and outcomes: Results from the Micra Transcatheter Pacing System Post-Approval Registry. HEART RHYTHM. 2022; 19(2)DOI:10.1016/j.hrthm.2021.10.023. PMID:34757189. IF:5.500(Q2/3D).
01/02/2022
Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension
Asmarats, L, Bethencourt, A, Rodriguez, A, Noris, M, Maristany, J, Grau, A, Gomez-Jaume, A, Peral, V. Ruptured sinus of Valsalva aneurysm: A reversible cause of suprasystemic pulmonary hypertension. Revista Portuguesa de Cardiologia. 2022; 41(2)DOI:10.1016/j.repc.2018.10.016. PMID:36062706. IF:1.800(Q4/8D).
01/02/2022
Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries)
Vilades-Medel, D, Degano, IR, Subirana, I, Descalzo, M, Padilla, M, Mundet, X, Costa, FC, Serrallach, XA, Camps, A, Elosua, R, Marrugat, J, Petracca, RL. Usefulness of Cardiac Computed Tomography in Coronary Risk Prediction: A Five-Year Follow-Up of the SPICA Study (Secure Prevention with Imaging of the Coronary Arteries). Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030533. PMID:35159985. IF:3.900(Q2/4D).
01/02/2022
Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study
Jimenez-Yuste, V, Alvarez-Roman, MT, Bravo, AP, Galmes, BJ, Hernandez, MDN, Hidalgo, OB, Alonso, CM, Gonzalez, NFP, Coll, J, Nunez, R, Carrasco, M, Candel, FG, Gonzalez-Porras, JR, Garcia, CH, Castro, MJV, Mir, R. Clinical Efficacy and Safety of Fanhdi(R), a Plasma-Derived VWF/Factor VIII Concentrate, in von Willebrand Disease in Spain: A Retrospective Study. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS. 2022; 28DOI:10.1177/10760296221074348. PMID:35108125. IF:2.900(Q3/6D).
01/02/2022
Network-Assisted Systems Biology Analysis of the Mitochondrial Proteome in a Pre-Clinical Model of Ischemia, Revascularization and Post-Conditioning
Gallinat, A, Vilahur, G, Padro, T, Badimon, L. Network-Assisted Systems Biology Analysis of the Mitochondrial Proteome in a Pre-Clinical Model of Ischemia, Revascularization and Post-Conditioning. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042087. PMID:35216205. IF:5.600(Q1/3D).
01/02/2022
Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells
Benitez-Amaro, A, Martinez-Bosch, N, Manero-Ruperez, N, Claudi, L, Lhoest, MTL, Soler, M, Ros-Blanco, L, Navarro, P, Llorente-Cortes, V. Peptides against Low Density Lipoprotein (LDL) Aggregation Inhibit Intracellular Cholesteryl Ester Loading and Proliferation of Pancreatic Tumor Cells. Cancers. 2022; 14(4)DOI:10.3390/cancers14040890. PMID:35205638. IF:5.200(Q2/3D).
01/02/2022
Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis
Nunez, E, Fuster, V, Gomez-Serrano, M, Valdivielso, JM, Fernandez-Alvira, JM, Martinez-Lopez, D, Rodriguez, JM, Bonzon-Kulichenko, E, Calvo, E, Alfayate, A, Bermudez-Lopez, M, Escola-Gil, JC, Fernandez-Friera, L, Cerro-Pardo, I, Mendiguren, JM, Sanchez-Cabo, F, Sanz, J, Ordovas, JM, Blanco-Colio, LM, Garcia-Ruiz, JM, Ibanez, B, Lara-Pezzi, E, Fernandez-Ortiz, A, Martin-Ventura, JL, Vazquez, J. Unbiased plasma proteomics discovery of biomarkers for improved detection of subclinical atherosclerosis. EBioMedicine. 2022; 76DOI:10.1016/j.ebiom.2022.103874. PMID:35152150. IF:11.100(Q1/1D).
01/02/2022
Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data
Magliano, DJ, Chen, L, Carstensen, B, Gregg, EW, Pavkov, ME, Salim, A, Andes, LJ, Balicer, R, Baviera, M, Chan, JCN, Cheng, YLJ, Gardiner, H, Gulseth, HL, Gurevicius, R, Ha, KH, Jermendy, G, Kim, DJ, Kiss, Z, Leventer-Roberts, M, Lin, CY, Luk, AOY, Ma, S, Mata-Cases, M, Mauricio, D, Nichols, GA, Pildava, S, Porath, A, Read, SH, Robitaille, C, Roncaglioni, MC, Ruiz, PLD, Wang, KL, Wild, SH, Yekutiel, N, Shaw, JE. Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data. Lancet Diabetes & Endocrinology. 2022; 10(2)DOI:10.1016/S2213-8587(21)00327-2. PMID:35026157. IF:44.500(Q1/1D).
01/02/2022
Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database
Franch-Nadal, J, Real, J, Mata-Cases, M, Ortega, E, Valles, JA, Vlacho, B, Mauricio, D. Compliance with the DPP-4 inhibitors dose adjustment recommendations based onrenal function in a population database. Endocrinologia Diabetes y Nutricion. 2022; 69(2)DOI:10.1016/j.endinu.2021.01.013. PMID:34088634. IF:1.900(Q4/9D).
01/02/2022
Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834
Meek, CL, Oram, RA, McDonald, TJ, Feig, DS, Hattersley, AT, Murphy, HR, Corcoy R., CHICO BALLESTEROS, ANA ISABEL, CONCEPTT Collaborative Grp. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834. DIABETES CARE. 2022; 45(2)DOI:10.2337/dci21-0054. PMID:35050370. IF:16.200(Q1/1D).
01/02/2022
Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response
Gil, J, Marques-Pamies, M, Valassi, E, Garcia-Martinez, A, Serra, G, Hostalot, C, Fajardo-Montanana, C, Carrato, C, Bernabeu, I, Marazuela, M, Rodriguez-Lloveras, H, Camara, R, Salinas, I, Lamas, C, Biagetti, B, Simo-Servat, A, Webb, SM, Pico, A, Jorda, M, Puig-Domingo, M. Implications of Heterogeneity of Epithelial-Mesenchymal States in Acromegaly Therapeutic Pharmacologic Response. Biomedicines. 2022; 10(2)DOI:10.3390/biomedicines10020460. PMID:35203668. IF:4.700(Q1/3D).
01/02/2022
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Pardo, JC, de Porras, VR, Gil, J, Font, A, Puig-Domingo, M, Jorda, M. Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer. Nutrients. 2022; 14(4)DOI:10.3390/nu14040851. PMID:35215499. IF:5.900(Q1/2D).
01/02/2022
Predictors of the need for necrosectomy in patients with walled-off pancreatic necrosis treated with lumen apposition metal stents
Gonzalez-Gonzalez, L, Bazaga, S, Murzi, M, Brujats, A, Trias, M, de Riba, B, Romito, R, Colan-Hernandez, J, Concepcion, M, Gordillo, J, Pernas, JC, Poca, M, Soriano, G, Guarner-Argente, C. Predictors of the need for necrosectomy in patients with walled-off pancreatic necrosis treated with lumen apposition metal stents. SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. 2022; 36(2)DOI:10.1007/s00464-021-08411-3. PMID:33660124. IF:3.100(Q1/3D).
01/02/2022
Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients
Gutierrez, A, Zapater, P, Ricart, E, Gonzalez-Vivo, M, Gordillo, J, Olivares, D, Vera, I, Manosa, M, Gisbert, JP, Aguas, M, Sanchez-Rodriguez, E, Bosca-Watts, M, Laredo, V, Camps, B, Marin-Jimenez, I, Zabana, Y, Martin-Arranz, MD, Munoz, R, Navarro, M, Sierra, E, Madero, L, Vela, M, Perez-Calle, JL, Sainz, E, Calvet, X, Arias, L, Morales, V, Bermejo, F, Fernandez-Salazar, L, Van Domselaar, M, De Castro, L, Rodriguez, C, Munoz-Villafranca, C, Lorente, R, Rivero, M, Iglesias, E, Herreros, B, Busquets, D, Riera, J, Martinez-Montiel, MP, Roldon, M, Roncero, O, Hinojosa, E, Sierra, M, Barrio, J, De Francisco, R, Huguet, J, Merino, O, Carpio, D, Ginard, D, Munoz, F, Marta, P, Almela, P, Argueelles-Arias, F, Alcain, G, Luis, B, Mancenido, N, Lucendo, AJ, Varela, P, Rodriguez-Lago, I, Ramos, L, Laura, S, Sese, E, Acosta, MBD, Domenech, E, Frances, R. Immigrant IBD Patients in Spain Are Younger, Have More Extraintestinal Manifestations and Use More Biologics Than Native Patients. Frontiers in Medicine. 2022; 9DOI:10.3389/fmed.2022.823900. PMID:35178413. IF:3.900(Q2/4D).
01/02/2022
Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity
Bermudo, G, Suarez-Cuartin, G, Rivera-Ortega, P, Rodriguez-Portal, JA, Sauleda, J, Nunez, B, Castillo, D, Aburto, M, Portillo, K, Balcells, E, Badenes-Bonet, D, Valenzuela, C, Fernandez-Fabrellas, E, Gonzalez-Budino, T, Cano, E, Acosta, O, Leiro-Fernandez, V, Romero, A, Planas-Cerezales, L, Villar, A, Moreno, A, Laporta, R, Vicens-Zygmunt, V, Shull, J, Franquet, T, Luburich, P, Molina-Molina, M. Different Faces of Idiopathic Pulmonary Fibrosis With Preserved Forced Vital Capacity. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.03.018. PMID:33895005. IF:8.000(Q1/2D).
01/02/2022
Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies
Plaza, V, Alobid, I, Alvarez, C, Blanco, M, Ferreira, J, Garcia, G, Gomez-Outes, A, Gomez, F, Hidalgo, A, Korta, J, Molina, J, Pellegrini, FJ, Perez, M, Plaza, J, Praena, M, Quirce, S, Sanz, J. Spanish Asthma Management Guidelines (GEMA) VERSION 5.1. Highlights and Controversies. ARCHIVOS DE BRONCONEUMOLOGIA. 2022; 58(2)DOI:10.1016/j.arbres.2021.05.010. PMID:34167859. IF:8.000(Q1/2D).
01/02/2022
The endocrine role of brown adipose tissue: An update on actors and actions
Gavalda-Navarro, A, Villarroya, J, Cereijo, R, Giralt, M, Villarroya, F. The endocrine role of brown adipose tissue: An update on actors and actions. REVIEWS IN ENDOCRINE & METABOLIC DISORDERS. 2022; 23(1)DOI:10.1007/s11154-021-09640-6. PMID:33712997. IF:8.200(Q1/1D).
01/02/2022
Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy
Domingo, P, Mateo, MG, Villarroya, J, Cereijo, R, Torres, F, Domingo, JC, Campderros, L, Gallego-Escuredo, JM, Gutierrez, MD, Mur, I, Corbacho, N, Vidal, F, Villarroya, F, Giralt, M. Increased Circulating Levels of Growth Differentiation Factor 15 in Association with Metabolic Disorders in People Living with HIV Receiving Combined Antiretroviral Therapy. Journal of Clinical Medicine. 2022; 11(3)DOI:10.3390/jcm11030549. PMID:35160008. IF:3.900(Q2/4D).
01/02/2022
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy
Yeregui, E, Masip, J, Vilades, C, Domingo, P, Pacheco, YM, Blanco, J, Mallolas, J, Alba, V, Vargas, M, Garcia-Pardo, G, Negredo, E, Olona, M, Vidal-Gonzalez, J, Peraire, M, Marti, A, Reverte, L, Gomez-Bertomeu, F, Leal, M, Vidal, F, Peraire, J, Rull, A. Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4(+) T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022; 23(4)DOI:10.3390/ijms23042202. PMID:35216318. IF:5.600(Q1/3D).
01/02/2022
A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial
Sooy, RA, Han, JY, Dafni, U, Cho, BC, Yeo, CM, Nadal, E, Carcereny, E, de Castro, J, Sala, MA, Bernabee, R, Coate, L, Pulla, MP, Campelo, RG, Cuffe, S, Hashemi, SMS, Fruh, M, Massuti, B, Garcia-Sanchez, J, Domine, M, Majem, M, Sanchez-Torres, JM, Britschgi, C, Pless, M, Dimopoulou, G, Roschitzki-Voser, H, Ruepp, B, Rosell, R, Stahel, RA, Peters, S. A randomised phase II study of osimertinib and bevacizumab versus osimertinib alone as second-line targeted treatment in advanced NSCLC with confirmed EGFR and acquired T790M mutations: the European Thoracic Oncology Platform (ETOP 10-16) BOOSTER trial. ANNALS OF ONCOLOGY. 2022; 33(2)DOI:10.1016/j.annonc.2021.11.010. PMID:34839016. IF:50.500(Q1/1D).